Despite its potential, biofabrication faces several challenges, such as:
Scalability: Scaling up the production of biofabricated tissues to a clinically relevant size. Biocompatibility: Ensuring that the materials used do not elicit adverse immune responses. Complexity: Replicating the complex architecture and functions of natural tissues. Regulatory Hurdles: Navigating the stringent regulatory requirements for clinical applications.
